| Literature DB >> 25062015 |
Xiaohan Yin1, Huili Wang2, Yuna Zhang1, Randy A Dahlgren1, Hongqin Zhang2, Mengru Shi2, Ming Gao1, Xuedong Wang1.
Abstract
β-Diketone antibiotics (DKAs) can produce chronic toxicity in aquatic ecosystems due to their pseudo-persistent in the environment. In this study, after long-term DKA exposure to zebrafish (Danio rerio), 47 protein spots had greater than 2-fold differential expression as compared to the control; there were 26 positive proteins with 14 up-regulated and 12 down-regulated. The main functions of the differentially expressed proteins were related to signal transduction mechanisms and the cytoskeleton. Of the 26 target genes, 11 genes were consistent between their transcriptional and translational levels. Low dose DKA exposure (4.69 and 9.38 mg/L) stimulated spontaneous movement in zebrafish. Changes in both creatine kinase activity and creatine concentration showed a similar trend to zebrafish activity. There was no obvious change in SV-BA after DKA exposure, while a reduction of heart rate was concomitant with increasing DKA concentrations. DKAs also induced severe histopathological changes in zebrafish heart tissue, such as dissolution of cristae and vacuolation of mitochondria. These results demonstrated that trace-level DKA exposure affects a variety of cellular and biological processes in zebrafish.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25062015 PMCID: PMC4111491 DOI: 10.1371/journal.pone.0102731
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Chemical structures for each DKA compound.
Figure 2The differential protein spots between the DKA treatments and control groups.
Note: The differential protein spots had >2.0-fold changes in the DKA treatment groups compared to the control group.
The differential protein spots between control and DKA-exposed treatments by MALDI-TOF-MS.
| Spot# | Accession NO. | Gene product | MW(kDa) | pI | Matched Peptides | Cov | Score | E-value | Fold change (Mean ± SD) | Location chromosome |
| 2416 | gi|57222259 | Talin-1 | 272579 | 5.86 | 28 | 14% | 68 | 0.006 | −2.19±0.46 | 10 |
| 2411 | gi|45387723 | Uncharacterized protein LOC402952 | 37349 | 9.23 | 7 | 36% | 58 | 0.055 | −3.64±0.05 | 21 |
| 2327 | gi|41944596 | Heat shock protein 4 | 95585 | 5.10 | 17 | 24% | 63 | 0.020 | −2.34±0.71 | 14 |
| 6459 | gi|326666090 | Multidrug resistance-associated protein 1-like | 228609 | 8.71 | 15 | 10% | 64 | 0.014 | −3.53±0.39 | 3 |
| 4407 | gi|366039974 | ATP synthase subunit beta, mitochondrial | 55210 | 5.14 | 12 | 30% | 76 | 0.001 | −3.51±0.05 | 11 |
| 3502 | gi|82181062 | Beta-coat protein | 108047 | 5.72 | 17 | 24% | 62 | 0.023 | −3.72±0.43 | 7 |
| 3730 | gi|300680985 | EF-hand calcium-binding domain-containing protein 4A | 46004 | 5.82 | 18 | 39% | 63 | 0.018 | −3.15±0.56 | 25 |
| 1325 | gi|18859049 | Myosin light chain, phosphorylatable, fast skeletal muscle a | 18967 | 4.68 | 11 | 72% | 90 | 4.1e-05 | −2.70±0.06 | 3 |
| 2203 | gi|62202893 | Mcm10 protein, partial | 37666 | 5.48 | 11 | 32% | 66 | 0.009 | −3.40±0.56 | 4 |
| 2350 | gi|18858249 | Actin, alpha cardiac muscle 1 | 42288 | 5.23 | 12 | 43% | 59 | 0.048 | −6.95±0.22 | 17 |
| 7301 | gi|42560193 | Actin, cytoplasmic 1, N-terminally processed | 42068 | 5.30 | 8 | 27% | 66 | 0.009 | −4.27±0.38 | 1 |
| 7309 | gi|55925421 | Uncharacterized protein LOC492776 | 27126 | 5.46 | 11 | 45% | 63 | 0.019 | −2.23±0.30 | 9 |
| 1561 | gi|125838841 | Acid sphingomyelinase-like phosphodiesterase 3b-like | 52763 | 6.73 | 10 | 21% | 67 | 0.008 | 3.76±0.33 | 16 |
| 1448 | gi|353558878 | Maternal embryonic leucine zipper kinase | 77612 | 8.88 | 7 | 18% | 59 | 0.050 | 3.77±0.05 | 1 |
| 3319 | gi|28277651 | Actin, alpha 1, skeletal muscle | 42298 | 5.23 | 15 | 47% | 72 | 0.003 | 5.02±0.13 | 17 |
| 4359 | gi|313482836 | Plasma membrane calcium ATPase 3a | 130715 | 5.41 | 15 | 14% | 69 | 0.005 | 2.10±0.40 | 8 |
| 5339 | gi|161612176 | LOC560422 protein, partial | 34141 | 8.56 | 9 | 32% | 58 | 0.062 | 5.98±0.32 | 2 |
| 5346 | gi|292619409 | Hypothetical protein LOC794259 | 291570 | 6.76 | 22 | 11% | 61 | 0.031 | 5.27±0.41 | 12 |
| 2359 | gi|62955473 | Actin, gamma-enteric smooth muscle | 42232 | 5.29 | 12 | 34% | 74 | 0.002 | 6.85±0.09 | 1 |
| 0297 | gi|61806478 | Cyclin-H | 37420 | 5.77 | 13 | 40% | 71 | 0.003 | 5.72±0.36 | 5 |
| 02105 | gi|120538416 | LOC557463 protein, partial | 42884 | 8.73 | 10 | 36% | 73 | 0.002 | 3.79±0.61 | 13 |
| 3225 | gi|161611678 | Zgc:171522 protein | 22889 | 9.04 | 9 | 38% | 64 | 0.016 | 4.73±0.23 | 1 |
| 4228 | gi|68398755 | Megakaryocyte-associated tyrosine-protein kinase | 50794 | 8.98 | 13 | 20% | 61 | 0.033 | 2.53±0.06 | 22 |
| 2258 | gi|41053317 | Developmentally-regulated GTP-binding protein 1 | 40726 | 8.83 | 9 | 21% | 65 | 0.013 | 4.44±0.64 | 10 |
| 8411 | gi|68353786 | Hypothetical protein LOC558776 | 54015 | 9.60 | 8 | 28% | 63 | 0.019 | 2.50±0.25 | 1 |
| 7648 | gi|326674120 | Vacuolar protein sorting-associated protein 37B-like | 34412 | 9.62 | 6 | 20% | 62 | 0.026 | 3.18±0.42 | 15 |
Note: In “fold change” column, “+” indicates up-regulation, and “−” denotes down-regulation, respectively.
Figure 3The relative mRNA transcription levels and translation levels of the positive proteins.
Figure 4The swimming speed of larvae exposed to various DKA concentrations from 6 to 96(A) or a 50 min dark-to-light photoperiod (B) at 120 hpf.
Figure 5The effects of DKA concentrations on CK activities and Cr concentrations.
Figure 6The heart rate of zebrafish under different DKA concentrations.
Figure 7Histopathological analysis of heart tissue.